DGIdb - VALDECOXIB Drug Record

VALDECOXIB chembl:CHEMBL865

Alternate Names:

VALDECOXIB
BEXTRA
SC-65872
P-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)BENZENESULFONAMIDE
BEXTRA®
4-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)BENZENESULFONAMIDE
chembl:CHEMBL865
rxcui:278567
pubchem.compound:119607
chemidplus:181695-72-7
drugbank:00580

Drug Info:

(2 More Sources)

Publications:

Grosser T, 2009, Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy., J Investig Med
Tacconelli et al., 2002, The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity., Curr Med Res Opin
Jain, 2000, Evaluation of intravenous parecoxib for the relief of acute post-surgical pain., Expert Opin Investig Drugs
Yuan et al., 2002, Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human., Drug Metab. Dispos.
Gierse et al., 2005, Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity., J. Pharmacol. Exp. Ther.
Talley et al., 2000, 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2., J. Med. Chem.
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
Hood et al., 2003, Characterization of celecoxib and valdecoxib binding to cyclooxygenase., Mol. Pharmacol.
Onnis V et al., 2010, Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors., J Med Chem
Pyrko et al., 2006, Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo., Mol. Cancer

VALDECOXIB PTGS2

Interaction Score: 4.84

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Cyclooxygenase-2 inhibitor

Direct Interaction yes

PMIDs:
19602986 12564662 11060833 12167567 15494548 10715145 11752352 12644588 20143779

Sources:
DTC ChemblInteractions PharmGKB TTD
VALDECOXIB BIRC5

Interaction Score: 1.72

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16707021

Sources:
NCI

NCI: VALDECOXIB

Version: 14-September-2017

Alternate Names:

C1869 NCI drug code

Drug Info:

Publications:

Pyrko et al., 2006, Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo., Mol. Cancer

DTC: VALDECOXIB
- Version: 02-September-2020
Alternate Names:

CHEMBL865 ChEMBL Drug ID

Drug Info:

Publications:

Onnis V et al., 2010, Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors., J Med Chem
PharmGKB: valdecoxib
- Version: 18-August-2020
Alternate Names:

Drug Info:

Publications:

Grosser T, 2009, Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy., J Investig Med
TTD: Valdecoxib
- Version: 2020.06.01
Alternate Names:

D0L6DA TTD Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL865
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:
ChemblInteractions: CHEMBL865
- Version: chembl_23
Alternate Names:

Drug Info:

Publications:

Mechanism of Interaction	Cyclooxygenase-2 inhibitor
Direct Interaction	yes

VALDECOXIB Drug Record

VALDECOXIB chembl:CHEMBL865

Alternate Names:

Drug Info:

Publications:

VALDECOXIB PTGS2

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Cyclooxygenase-2 inhibitor Direct Interaction yes

PMIDs: 19602986 12564662 11060833 12167567 15494548 10715145 11752352 12644588 20143779

Sources: DTC ChemblInteractions PharmGKB TTD

VALDECOXIB BIRC5

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16707021

Sources: NCI

NCI: VALDECOXIB

Alternate Names: C1869 NCI drug code

Drug Info:

Publications: Pyrko et al., 2006, Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo., Mol. Cancer

DTC: VALDECOXIB

Alternate Names: CHEMBL865 ChEMBL Drug ID

Drug Info:

Publications: Onnis V et al., 2010, Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors., J Med Chem

PharmGKB: valdecoxib

Alternate Names:

Drug Info:

Publications: Grosser T, 2009, Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy., J Investig Med

TTD: Valdecoxib

Alternate Names: D0L6DA TTD Drug ID

Drug Info:

Publications:

ChemblDrugs: chembl:CHEMBL865

Alternate Names:

Drug Info:

Publications:

ChemblInteractions: CHEMBL865

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Cyclooxygenase-2 inhibitor

Direct Interaction yes

PMIDs:
19602986 12564662 11060833 12167567 15494548 10715145 11752352 12644588 20143779

Sources:
DTC ChemblInteractions PharmGKB TTD

Interaction Types & Directionality:

n/a

PMIDs:
16707021

Sources:
NCI

Alternate Names:

C1869 NCI drug code

Publications:

Pyrko et al., 2006, Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo., Mol. Cancer

Alternate Names:

CHEMBL865 ChEMBL Drug ID

Publications:

Onnis V et al., 2010, Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors., J Med Chem

Publications:

Grosser T, 2009, Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy., J Investig Med

Alternate Names:

D0L6DA TTD Drug ID